PTEN, the first tumor suppressor gene identified with tyrosine phosphatase activity (93), is a potent negative regulator of AKT and plays a crucial role in controlling PI3K/AKT signaling activation (94). The gene discussed is PIK3CB; the disease is neoplasm.